These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

89 related items for PubMed ID: 10209488

  • 1. Interaction between endothelial cells and the secreted cytokine drives the fate of an IL4- or an IL5-transduced tumour.
    Di Carlo E, Modesti A, Coletti A, Colombo MP, Giovarelli M, Forni G, Diodoro MG, Musiani P.
    J Pathol; 1998 Dec; 186(4):390-7. PubMed ID: 10209488
    [Abstract] [Full Text] [Related]

  • 2. Role of neutrophils and lymphocytes in inhibition of a mouse mammary adenocarcinoma engineered to release IL-2, IL-4, IL-7, IL-10, IFN-alpha, IFN-gamma, and TNF-alpha.
    Musiani P, Allione A, Modica A, Lollini PL, Giovarelli M, Cavallo F, Belardelli F, Forni G, Modesti A.
    Lab Invest; 1996 Jan; 74(1):146-57. PubMed ID: 8569177
    [Abstract] [Full Text] [Related]

  • 3. Local release of interleukin-10 by transfected mouse adenocarcinoma cells exhibits pro- and anti-inflammatory activity and results in a delayed tumor rejection.
    Di Carlo E, Coletti A, Modesti A, Giovarelli M, Forni G, Musiani P.
    Eur Cytokine Netw; 1998 Mar; 9(1):61-8. PubMed ID: 9613679
    [Abstract] [Full Text] [Related]

  • 4. Interleukin 6 gene-transfected mouse mammary adenocarcinoma: tumour cell growth and metastatic potential.
    Di Carlo E, Modesti A, Castrilli G, Landuzzi L, Allione A, de Giovanni C, Musso T, Musiani P.
    J Pathol; 1997 May; 182(1):76-85. PubMed ID: 9227345
    [Abstract] [Full Text] [Related]

  • 5. Local release of IL-10 by transfected mouse mammary adenocarcinoma cells does not suppress but enhances antitumor reaction and elicits a strong cytotoxic lymphocyte and antibody-dependent immune memory.
    Giovarelli M, Musiani P, Modesti A, Dellabona P, Casorati G, Allione A, Consalvo M, Cavallo F, di Pierro F, De Giovanni C.
    J Immunol; 1995 Sep 15; 155(6):3112-23. PubMed ID: 7673726
    [Abstract] [Full Text] [Related]

  • 6. Nature and potential of the reactive response to mouse mammary adenocarcinoma cells engineered with interleukin-2, interleukin-4 or interferon-gamma genes.
    Musiani P, Modesti A, Brunetti M, Modica A, Vitullo P, Gulino A, Bosco MC, Colombo MP, Nanni P, Cavallo F.
    Nat Immun; 1994 Sep 15; 13(2-3):93-101. PubMed ID: 8173240
    [Abstract] [Full Text] [Related]

  • 7. In vitro growth of TS/A adenocarcinoma and of the gene transfected TS/A-IL4 line on biological substrates.
    Pacor S, Magnarin M, Carotenuto ME, Spessotto P, Zabucchi G, Sava G.
    Anticancer Res; 2000 Sep 15; 20(1A):191-6. PubMed ID: 10769654
    [Abstract] [Full Text] [Related]

  • 8. Antitumor effect of interleukin (IL)-12 in the absence of endogenous IFN-gamma: a role for intrinsic tumor immunogenicity and IL-15.
    Gri G, Chiodoni C, Gallo E, Stoppacciaro A, Liew FY, Colombo MP.
    Cancer Res; 2002 Aug 01; 62(15):4390-7. PubMed ID: 12154045
    [Abstract] [Full Text] [Related]

  • 9. Cytokine gene therapy of gliomas: effective induction of therapeutic immunity to intracranial tumors by peripheral immunization with interleukin-4 transduced glioma cells.
    Okada H, Villa L, Attanucci J, Erff M, Fellows WK, Lotze MT, Pollack IF, Chambers WH.
    Gene Ther; 2001 Aug 01; 8(15):1157-66. PubMed ID: 11509946
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. A "stealth effect": adenocarcinoma cells engineered to express TRAIL elude tumor-specific and allogeneic T cell reactions.
    Giovarelli M, Musiani P, Garotta G, Ebner R, Di Carlo E, Kim Y, Cappello P, Rigamonti L, Bernabei P, Novelli F, Modesti A, Coletti A, Ferrie AK, Lollini PL, Ruben S, Salcedo T, Forni G.
    J Immunol; 1999 Nov 01; 163(9):4886-93. PubMed ID: 10528190
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Interferon-alpha gene therapy in combination with CD80 transduction reduces tumorigenicity and growth of established tumor in poorly immunogenic tumor models.
    Hiroishi K, Tüting T, Tahara H, Lotze MT.
    Gene Ther; 1999 Dec 01; 6(12):1988-94. PubMed ID: 10637450
    [Abstract] [Full Text] [Related]

  • 19. Immunization with an antigen identified by cytokine tumor vaccine-assisted SEREX (CAS) suppressed growth of the rat 9L glioma in vivo.
    Okada H, Attanucci J, Giezeman-Smits KM, Brissette-Storkus C, Fellows WK, Gambotto A, Pollack LF, Pogue-Geile K, Lotze MT, Bozik ME, Chambers WH.
    Cancer Res; 2001 Mar 15; 61(6):2625-31. PubMed ID: 11289140
    [Abstract] [Full Text] [Related]

  • 20. IL4 gene delivery to the CNS recruits regulatory T cells and induces clinical recovery in mouse models of multiple sclerosis.
    Butti E, Bergami A, Recchia A, Brambilla E, Del Carro U, Amadio S, Cattalini A, Esposito M, Stornaiuolo A, Comi G, Pluchino S, Mavilio F, Martino G, Furlan R.
    Gene Ther; 2008 Apr 15; 15(7):504-15. PubMed ID: 18239607
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.